TickerFacts.

Palvella Therapeutics, Inc. (PVLA): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$171.0K
Year ended 2023-12-31
-60.3%
3-year compound annual growth
-36.8%
5-year compound annual growth
$2.73M2013-12-31: $49.5K2014-12-31: $267.4K2015-12-31: $620.7K2016-12-31: $560.0K2017-12-31: $1.95M2018-12-31: $1.70M2019-12-31: $2.46M2020-12-31: $2.73M2021-12-31: $949.0K2022-12-31: $1.04M2023-12-31: $171.0K$171.0K
2013-12-31 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$171.0K-83.6%2024-03-29, From 2023-01-01
2022-12-31$1.04M+9.7%2024-03-29, From 2022-01-01
2021-12-31$949.0K-65.2%2023-03-31, From 2021-01-01
2020-12-31$2.73M+10.7%2022-03-02, From 2020-01-01
2019-12-31$2.46M+45.0%2021-03-31, From 2019-01-01
2018-12-31$1.70M-12.9%2020-03-13, From 2018-01-01
2017-12-31$1.95M+248.2%2019-03-18, From 2017-01-01
2016-12-31$560.0Kn/c2018-03-15, From 2016-01-01
2015-12-31$620.7K+132.1%2017-03-30, From 2015-01-01
2014-12-31$267.4K+440.5%2016-03-23, From 2014-01-01
2013-12-31$49.5Kn/a2015-03-30, From 2013-01-01